Kyowa Hakko Kirin And Hisamitsu To Jointly Distribute Cancer Pain Drug
This article was originally published in PharmAsia News
Executive Summary
Kyowa Hakko Kirin Feb. 1 entered a joint distribution agreement with Hisamitsu Pharmaceutical for cancer pain drug KW-2246 (fentanyl), which was licensed from Sweden firm Orexo